Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 16Withdrawn 1Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 1

Interventions

Docetaxel 33Radiosurgery 22Radiotherapy 21Sunitinib 20pembrolizumab 18Gemcitabine 16Cisplatin 16Androgen Antagonists 15enzalutamide 13Nivolumab 13Prednisone 12Goserelin 12Blood Specimen Collection 12Abiraterone Acetate 12aldesleukin 11Surveys and Questionnaires 11Leuprolide 11Cyclophosphamide 11bicalutamide 10Bevacizumab 10Multiparametric Magnetic Resonance Imaging 9Gonadotropin-Releasing Hormone 9Carboplatin 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Filgrastim 8Epirubicin 8Chemotherapy, Adjuvant 8Brachytherapy 8toripalimab 7tislelizumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lycopene × Genitourinary × Clear all
NCT00322114 2013-09-20

Lycopene in Preventing Prostate Cancer in Healthy Participants

National Cancer Institute (NCI)

Phase NA Unknown
150 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡